Table VII.
Vimentin expression | ||||||
---|---|---|---|---|---|---|
Clinicopathological parameters | Total number of cases (n) | Negative | Positive | Positive rate (%) | χ2 value | P-value |
Age (years) | ||||||
<53 | 154 | 53 | 101 | 65.6 | 0.009 | 0.925 |
≥53 | 146 | 51 | 95 | 65.1 | ||
Pathological type | ||||||
Serous carcinoma | 168 | 56 | 112 | 66.7 | 0.372 | 0.946 |
Mucinous carcinoma | 63 | 23 | 40 | 63.5 | ||
Endometrial carcinoma | 54 | 20 | 34 | 63.0 | ||
Clear cell carcinoma | 15 | 5 | 10 | 66.7 | ||
FIGO staging | ||||||
I–II | 143 | 85 | 58 | 40.6 | 74.046 | <0.001 |
III–IV | 157 | 19 | 138 | 87.9 | ||
Pathological staging | ||||||
G1+G2 | 124 | 76 | 48 | 38.7 | 66.148 | <0.001 |
G3 | 176 | 28 | 148 | 84.1 | ||
Lymph node metastasis | ||||||
Yes | 186 | 38 | 148 | 79.6 | 43.802 | <0.001 |
No | 114 | 66 | 48 | 42.1 |